JP2023525137A5 - - Google Patents
Info
- Publication number
- JP2023525137A5 JP2023525137A5 JP2022568879A JP2022568879A JP2023525137A5 JP 2023525137 A5 JP2023525137 A5 JP 2023525137A5 JP 2022568879 A JP2022568879 A JP 2022568879A JP 2022568879 A JP2022568879 A JP 2022568879A JP 2023525137 A5 JP2023525137 A5 JP 2023525137A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025244683A JP2026048803A (ja) | 2020-05-14 | 2025-12-10 | Ｃｙｐ１１ａ１阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20205486 | 2020-05-14 | ||
| FI20205486 | 2020-05-14 | ||
| PCT/FI2021/050353 WO2021229152A1 (en) | 2020-05-14 | 2021-05-12 | Cyp11a1 inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025244683A Division JP2026048803A (ja) | 2020-05-14 | 2025-12-10 | Ｃｙｐ１１ａ１阻害剤 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023525137A JP2023525137A (ja) | 2023-06-14 |
| JPWO2021229152A5 JPWO2021229152A5 (https=) | 2024-05-22 |
| JP2023525137A5 true JP2023525137A5 (https=) | 2024-05-22 |
| JP7789697B2 JP7789697B2 (ja) | 2025-12-22 |
Family
ID=76325569
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568879A Active JP7789697B2 (ja) | 2020-05-14 | 2021-05-12 | Ｃｙｐ１１ａ１阻害剤 |
| JP2025244683A Pending JP2026048803A (ja) | 2020-05-14 | 2025-12-10 | Ｃｙｐ１１ａ１阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025244683A Pending JP2026048803A (ja) | 2020-05-14 | 2025-12-10 | Ｃｙｐ１１ａ１阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230192677A1 (https=) |
| EP (1) | EP4149924A1 (https=) |
| JP (2) | JP7789697B2 (https=) |
| KR (1) | KR20230010723A (https=) |
| CN (1) | CN115551831A (https=) |
| AU (1) | AU2021269872A1 (https=) |
| CA (1) | CA3178067A1 (https=) |
| WO (1) | WO2021229152A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117242056A (zh) * | 2021-03-26 | 2023-12-15 | 北京加科思新药研发有限公司 | 用作sting激动剂的新型化合物及其用途 |
| PE20241583A1 (es) * | 2021-09-28 | 2024-08-01 | Orion Corp | Inhibidor de cyp11a1 para su uso en el tratamiento del cancer de prostata |
| WO2023084158A1 (en) * | 2021-11-10 | 2023-05-19 | Orion Corporation | Cyp11a1 inhibitors |
| CN115304591B (zh) * | 2022-07-08 | 2024-10-01 | 广州中医药大学(广州中医药研究院) | 一种桥环甾体合成酶抑制剂及其制备方法和应用 |
| CN118307519A (zh) * | 2023-01-06 | 2024-07-09 | 上海闻耐医药科技有限公司 | 一类cyp11a1抑制剂化合物及其制备方法和用途 |
| WO2024199262A1 (zh) * | 2023-03-29 | 2024-10-03 | 西藏海思科制药有限公司 | Cyp11a1抑制剂及其用途 |
| WO2024199421A1 (zh) * | 2023-03-30 | 2024-10-03 | 山东轩竹医药科技有限公司 | Cyp11a1抑制剂 |
| CN121039123A (zh) * | 2023-04-21 | 2025-11-28 | 西藏海思科制药有限公司 | Cyp11a1抑制剂及其用途 |
| AU2024270498A1 (en) * | 2023-05-11 | 2025-11-27 | Foshan Ionova Biotherapeutics Co., Inc. | Novel compounds as cyp11a1 inhibitors and methods of use thereof |
| CN121605106A (zh) * | 2023-07-27 | 2026-03-03 | 优领医药科技(香港)有限公司 | Cyp11a1抑制剂 |
| CN121889383A (zh) * | 2023-09-08 | 2026-04-17 | 深圳众格生物科技有限公司 | 一种cyp11a1抑制剂、其制备方法及其应用 |
| WO2025168117A1 (zh) * | 2024-02-08 | 2025-08-14 | 盛睿泽华医药科技（苏州）有限公司 | 一种多环化合物及其制备方法和应用 |
| WO2025237211A1 (zh) * | 2024-05-11 | 2025-11-20 | 辽宁海思科制药有限公司 | 一种cyp11a1抑制剂的晶型物及其制备方法和应用 |
| WO2025247149A1 (zh) * | 2024-05-27 | 2025-12-04 | 辽宁海思科制药有限公司 | 一种cyp11a1抑制剂的盐及其晶型、其制备方法和应用 |
| WO2026002207A1 (en) * | 2024-06-28 | 2026-01-02 | Acerand Therapeutics (Hong Kong) Limited | Heterocyclic compounds as cyp11a1 inhibitors |
| WO2026040949A1 (zh) * | 2024-08-19 | 2026-02-26 | 辽宁海思科制药有限公司 | 一种cyp11a1抑制剂的药物组合物及其制备方法和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1471063A1 (en) | 2003-02-28 | 2004-10-27 | Exonhit Therapeutics S.A. | Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| AR088320A1 (es) | 2011-10-14 | 2014-05-28 | Incyte Corp | Derivados de isoindolinona y pirrolopiridinona como inhibidores de akt |
| US10357484B2 (en) | 2015-07-17 | 2019-07-23 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| AR110412A1 (es) * | 2016-12-22 | 2019-03-27 | Orion Corp | Inhibidores de la cyp11a1 |
-
2021
- 2021-05-12 AU AU2021269872A patent/AU2021269872A1/en active Pending
- 2021-05-12 US US17/924,857 patent/US20230192677A1/en active Pending
- 2021-05-12 JP JP2022568879A patent/JP7789697B2/ja active Active
- 2021-05-12 CA CA3178067A patent/CA3178067A1/en active Pending
- 2021-05-12 WO PCT/FI2021/050353 patent/WO2021229152A1/en not_active Ceased
- 2021-05-12 EP EP21730972.3A patent/EP4149924A1/en active Pending
- 2021-05-12 CN CN202180034328.3A patent/CN115551831A/zh active Pending
- 2021-05-12 KR KR1020227043775A patent/KR20230010723A/ko active Pending
-
2025
- 2025-12-10 JP JP2025244683A patent/JP2026048803A/ja active Pending